RE:RE:PEFECT TIME ....................Medmira has an amazing, adaptable product. Hermes is an innovator in all products. Typically they move through the system with FDA and Health Canada. It seems that the covid products is another story. Once a new product is developmed the mechanism for selling is HORRIlBLE.
Having said all that, the covid testing product will win the day. Demand is HUGE. At this moment the demand world wide is outstripping supply and demand will stay strong for a long time. Their product will be in demand and outlets will be seeking them. This demand will come their door, overcoming Medmiras sale foibles.
Medmira will have the cash flow the need to pay down debt.
I would not be surprised if they sold their company during a position of strength. I am sure that Hermes is wanting to retire and benefit from his years of development.
conservative2